267 related articles for article (PubMed ID: 28301876)
1. Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS.
Qu X; Sheng J; Shen L; Su J; Xu Y; Xie Q; Wu Y; Zhang X; Sun L
PLoS One; 2017; 12(3):e0173712. PubMed ID: 28301876
[TBL] [Abstract][Full Text] [Related]
2. Blockade of chloride channel-3 enhances cisplatin sensitivity of cholangiocarcinoma cells though inhibiting autophagy.
Han Y; Zhou Y; Zhou L; Jia X; Yu X; An X; Shi Z
Can J Physiol Pharmacol; 2022 Jul; 100(7):584-593. PubMed ID: 35413227
[TBL] [Abstract][Full Text] [Related]
3. Natural compound oblongifolin C inhibits autophagic flux, and induces apoptosis and mitochondrial dysfunction in human cholangiocarcinoma QBC939 cells.
Zhang A; He W; Shi H; Huang X; Ji G
Mol Med Rep; 2016 Oct; 14(4):3179-83. PubMed ID: 27499017
[TBL] [Abstract][Full Text] [Related]
4. Metformin sensitizes cholangiocarcinoma cell to cisplatin-induced cytotoxicity through oxidative stress mediated mitochondrial pathway.
Wandee J; Prawan A; Senggunprai L; Kongpetch S; Kukongviriyapan V
Life Sci; 2019 Jan; 217():155-163. PubMed ID: 30528773
[TBL] [Abstract][Full Text] [Related]
5. FOXO1, a Potential Therapeutic Target, Regulates Autophagic Flux, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Human Cholangiocarcinoma QBC939 Cells.
He W; Zhang A; Qi L; Na C; Jiang R; Fan Z; Chen J
Cell Physiol Biochem; 2018; 45(4):1506-1514. PubMed ID: 29466794
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory proteins FIP-gts and chloroquine induce caspase-independent cell death via autophagy for resensitizing cisplatin-resistant urothelial cancer cells.
Hsin IL; Wang SC; Li JR; Ciou TC; Wu CH; Wu HM; Ko JL
Phytomedicine; 2016 Dec; 23(13):1566-1573. PubMed ID: 27823620
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Wnt/β-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma.
Shen DY; Zhang W; Zeng X; Liu CQ
Cancer Sci; 2013 Oct; 104(10):1303-8. PubMed ID: 23822562
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial division inhibitor-1 potentiates cisplatin-induced apoptosis via the mitochondrial death pathway in cholangiocarcinoma cells.
Tusskorn O; Khunluck T; Prawan A; Senggunprai L; Kukongviriyapan V
Biomed Pharmacother; 2019 Mar; 111():109-118. PubMed ID: 30579250
[TBL] [Abstract][Full Text] [Related]
9. ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts.
Washington MN; Suh G; Orozco AF; Sutton MN; Yang H; Wang Y; Mao W; Millward S; Ornelas A; Atkinson N; Liao W; Bast RC; Lu Z
Cell Death Dis; 2015 Aug; 6(8):e1836. PubMed ID: 26247722
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis mechanism of human cholangiocarcinoma cells induced by bile extract from crocodile.
Kang JH; Zhang WQ; Song W; Shen DY; Li SS; Tian L; Shi Y; Liang G; Xiong YX; Chen QX
Appl Biochem Biotechnol; 2012 Feb; 166(4):942-51. PubMed ID: 22194052
[TBL] [Abstract][Full Text] [Related]
11. The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition.
Fukuda T; Oda K; Wada-Hiraike O; Sone K; Inaba K; Ikeda Y; Miyasaka A; Kashiyama T; Tanikawa M; Arimoto T; Kuramoto H; Yano T; Kawana K; Osuga Y; Fujii T
Gynecol Oncol; 2015 Jun; 137(3):538-45. PubMed ID: 25842161
[TBL] [Abstract][Full Text] [Related]
12. ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells.
Xu Y; Gao W; Zhang Y; Wu S; Liu Y; Deng X; Xie L; Yang J; Yu H; Su J; Sun L
Int J Oncol; 2018 Sep; 53(3):1055-1068. PubMed ID: 30015875
[TBL] [Abstract][Full Text] [Related]
13. Autophagy inhibition with chloroquine reverts paclitaxel resistance and attenuates metastatic potential in human nonsmall lung adenocarcinoma A549 cells via ROS mediated modulation of β-catenin pathway.
Datta S; Choudhury D; Das A; Mukherjee DD; Dasgupta M; Bandopadhyay S; Chakrabarti G
Apoptosis; 2019 Jun; 24(5-6):414-433. PubMed ID: 30767087
[TBL] [Abstract][Full Text] [Related]
14. SVCT-2 determines the sensitivity to ascorbate-induced cell death in cholangiocarcinoma cell lines and patient derived xenografts.
Wang C; Lv H; Yang W; Li T; Fang T; Lv G; Han Q; Dong L; Jiang T; Jiang B; Yang G; Wang H
Cancer Lett; 2017 Jul; 398():1-11. PubMed ID: 28385602
[TBL] [Abstract][Full Text] [Related]
15. Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.
Circu M; Cardelli J; Barr MP; O'Byrne K; Mills G; El-Osta H
PLoS One; 2017; 12(9):e0184922. PubMed ID: 28945807
[TBL] [Abstract][Full Text] [Related]
16. Chloroquine sensitizes hepatocellular carcinoma cells to chemotherapy via blocking autophagy and promoting mitochondrial dysfunction.
Zhang N; Xie H; Lu W; Li F; Li J; Guo Z
Int J Clin Exp Pathol; 2017; 10(9):10056-10065. PubMed ID: 31966896
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents.
Samatiwat P; Prawan A; Senggunprai L; Kukongviriyapan U; Kukongviriyapan V
Tumour Biol; 2016 Aug; 37(8):11495-507. PubMed ID: 27015836
[TBL] [Abstract][Full Text] [Related]
18. Fentanyl induces autophagy via activation of the ROS/MAPK pathway and reduces the sensitivity of cisplatin in lung cancer cells.
Yao J; Ma C; Gao W; Liang J; Liu C; Yang H; Yan Q; Wen Q
Oncol Rep; 2016 Dec; 36(6):3363-3370. PubMed ID: 27779694
[TBL] [Abstract][Full Text] [Related]
19. Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance.
Yu L; Gu C; Zhong D; Shi L; Kong Y; Zhou Z; Liu S
Cancer Lett; 2014 Dec; 355(1):34-45. PubMed ID: 25236911
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine potentiates temozolomide cytotoxicity by inhibiting mitochondrial autophagy in glioma cells.
Hori YS; Hosoda R; Akiyama Y; Sebori R; Wanibuchi M; Mikami T; Sugino T; Suzuki K; Maruyama M; Tsukamoto M; Mikuni N; Horio Y; Kuno A
J Neurooncol; 2015 Mar; 122(1):11-20. PubMed ID: 25528635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
